[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global (North America, Europe, Asia-Pacific, South America, Middle East and Africa) Flu Vaccine (Influenza Vaccine) Market 2018, Forecast to 2023

August 2018 | 135 pages | ID: GA7594B6B0CEN
GlobalInfoResearch

US$ 4,880.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
Influenza vaccines, also known as flu shots, are vaccines that protect against influenza. A new version of the vaccine is developed twice a year as the influenza virus rapidly changes. Most provide modest to high protection against influenza; however, each year this varies. Evidence in adults over 65 years old is poor. They decrease the number of missed days of work by a half day on average. Vaccinating children may protect those around them.

SCOPE OF THE REPORT:

This report focuses on the Flu Vaccine (Influenza Vaccine) in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
The classification of Flu Vaccine includes Whole Virus Vaccines, Split Virus Vaccines, Subunit Vaccines and Live Attenuated Virus Vaccines, and the proportion of Whole Virus Vaccines in 2016 is about 43%, and the proportion is in decreasing trend from 2012 to 2016.
Flu Vaccine is widely used for Children (6 months to 3 years) and for Adults and Children over 3 years. The most proportion of Flu Vaccine is For Adults and Children over 3 years, and the proportion in 2016 is about 75%.
The Europe in the EMEA is the largest consumption place, with a consumption market share nearly 80% in 2016. And in the major countries we mentioned in the report, Germany is the largest consumption place with the consumption market share of 12%. Following Russia, France is the second largest consumption region, with the proportion of 11%.

The worldwide market for Flu Vaccine (Influenza Vaccine) is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new GIR (Global Info Research) study.

Market Segment by Manufacturers, this report covers
  • CSL
  • GSK
  • Sanofi Pasteur
  • Mylan
  • AstraZeneca
  • Pfizer
  • Johnson & Johnson
Market Segment by Regions, regional analysis covers
  • North America (United States, Canada and Mexico)
  • Europe (Germany, France, UK, Russia and Italy)
  • Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
  • South America (Brazil, Argentina, Colombia etc.)
  • Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
  • Whole Virus Vaccines
  • Split Virus Vaccines
  • Subunit Vaccines
  • Live Attenuated Virus Vaccines
Market Segment by Applications, can be divided into
  • For Children (6 months to 3 years)
  • For Adults and Children over 3 years
There are 15 Chapters to deeply display the global Flu Vaccine (Influenza Vaccine) market.

Chapter 1, to describe Flu Vaccine (Influenza Vaccine) Introduction, product scope, market overview, market opportunities, market risk, market driving force;

Chapter 2, to analyze the top manufacturers of Flu Vaccine (Influenza Vaccine), with sales, revenue, and price of Flu Vaccine (Influenza Vaccine), in 2016 and 2017;

Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;

Chapter 4, to show the global market by regions, with sales, revenue and market share of Flu Vaccine (Influenza Vaccine), for each region, from 2013 to 2018;

Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;

Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;

Chapter 12, Flu Vaccine (Influenza Vaccine) market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;

Chapter 13, 14 and 15, to describe Flu Vaccine (Influenza Vaccine) sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source
1 MARKET OVERVIEW

1.1 Flu Vaccine (Influenza Vaccine) Introduction
1.2 Market Analysis by Type
  1.2.1 Whole Virus Vaccines
  1.2.2 Split Virus Vaccines
  1.2.3 Subunit Vaccines
  1.2.4 Live Attenuated Virus Vaccines
1.3 Market Analysis by Applications
  1.3.1 For Children (6 months to 3 years)
  1.3.2 For Adults and Children over 3 years
1.4 Market Analysis by Regions
  1.4.1 North America (United States, Canada and Mexico)
    1.4.1.1 United States Market States and Outlook (2013-2023)
    1.4.1.2 Canada Market States and Outlook (2013-2023)
    1.4.1.3 Mexico Market States and Outlook (2013-2023)
  1.4.2 Europe (Germany, France, UK, Russia and Italy)
    1.4.2.1 Germany Market States and Outlook (2013-2023)
    1.4.2.2 France Market States and Outlook (2013-2023)
    1.4.2.3 UK Market States and Outlook (2013-2023)
    1.4.2.4 Russia Market States and Outlook (2013-2023)
    1.4.2.5 Italy Market States and Outlook (2013-2023)
  1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
    1.4.3.1 China Market States and Outlook (2013-2023)
    1.4.3.2 Japan Market States and Outlook (2013-2023)
    1.4.3.3 Korea Market States and Outlook (2013-2023)
    1.4.3.4 India Market States and Outlook (2013-2023)
    1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)
  1.4.4 South America, Middle East and Africa
    1.4.4.1 Brazil Market States and Outlook (2013-2023)
    1.4.4.2 Egypt Market States and Outlook (2013-2023)
    1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)
    1.4.4.4 South Africa Market States and Outlook (2013-2023)
    1.4.4.5 Nigeria Market States and Outlook (2013-2023)
1.5 Market Dynamics
  1.5.1 Market Opportunities
  1.5.2 Market Risk
  1.5.3 Market Driving Force

2 MANUFACTURERS PROFILES

2.1 CSL
  2.1.1 Business Overview
    2.1.1.1 CSL Description
    2.1.1.2 CSL Headquarter, Main Business and Finance Overview
  2.1.2 CSL Flu Vaccine (Influenza Vaccine) Product Introduction
    2.1.2.1 Flu Vaccine (Influenza Vaccine) Production Bases, Sales Regions and Major Competitors
    2.1.2.2 Flu Vaccine (Influenza Vaccine) Product Information
  2.1.3 CSL Flu Vaccine (Influenza Vaccine) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.1.3.1 CSL Flu Vaccine (Influenza Vaccine) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.1.3.2 Global CSL Flu Vaccine (Influenza Vaccine) Market Share in 2017
2.2 GSK
  2.2.1 Business Overview
    2.2.1.1 GSK Description
    2.2.1.2 GSK Headquarter, Main Business and Finance Overview
  2.2.2 GSK Flu Vaccine (Influenza Vaccine) Product Introduction
    2.2.2.1 Flu Vaccine (Influenza Vaccine) Production Bases, Sales Regions and Major Competitors
    2.2.2.2 Flu Vaccine (Influenza Vaccine) Product Information
  2.2.3 GSK Flu Vaccine (Influenza Vaccine) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.2.3.1 GSK Flu Vaccine (Influenza Vaccine) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.2.3.2 Global GSK Flu Vaccine (Influenza Vaccine) Market Share in 2017
2.3 Sanofi Pasteur
  2.3.1 Business Overview
    2.3.1.1 Sanofi Pasteur Description
    2.3.1.2 Sanofi Pasteur Headquarter, Main Business and Finance Overview
  2.3.2 Sanofi Pasteur Flu Vaccine (Influenza Vaccine) Product Introduction
    2.3.2.1 Flu Vaccine (Influenza Vaccine) Production Bases, Sales Regions and Major Competitors
    2.3.2.2 Flu Vaccine (Influenza Vaccine) Product Information
  2.3.3 Sanofi Pasteur Flu Vaccine (Influenza Vaccine) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.3.3.1 Sanofi Pasteur Flu Vaccine (Influenza Vaccine) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.3.3.2 Global Sanofi Pasteur Flu Vaccine (Influenza Vaccine) Market Share in 2017
2.4 Mylan
  2.4.1 Business Overview
    2.4.1.1 Mylan Description
    2.4.1.2 Mylan Headquarter, Main Business and Finance Overview
  2.4.2 Mylan Flu Vaccine (Influenza Vaccine) Product Introduction
    2.4.2.1 Flu Vaccine (Influenza Vaccine) Production Bases, Sales Regions and Major Competitors
    2.4.2.2 Flu Vaccine (Influenza Vaccine) Product Information
  2.4.3 Mylan Flu Vaccine (Influenza Vaccine) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.4.3.1 Mylan Flu Vaccine (Influenza Vaccine) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.4.3.2 Global Mylan Flu Vaccine (Influenza Vaccine) Market Share in 2017
2.5 AstraZeneca
  2.5.1 Business Overview
    2.5.1.1 AstraZeneca Description
    2.5.1.2 AstraZeneca Headquarter, Main Business and Finance Overview
  2.5.2 AstraZeneca Flu Vaccine (Influenza Vaccine) Product Introduction
    2.5.2.1 Flu Vaccine (Influenza Vaccine) Production Bases, Sales Regions and Major Competitors
    2.5.2.2 Flu Vaccine (Influenza Vaccine) Product Information
  2.5.3 AstraZeneca Flu Vaccine (Influenza Vaccine) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.5.3.1 AstraZeneca Flu Vaccine (Influenza Vaccine) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.5.3.2 Global AstraZeneca Flu Vaccine (Influenza Vaccine) Market Share in 2017
2.6 Pfizer
  2.6.1 Business Overview
    2.6.1.1 Pfizer Description
    2.6.1.2 Pfizer Headquarter, Main Business and Finance Overview
  2.6.2 Pfizer Flu Vaccine (Influenza Vaccine) Product Introduction
    2.6.2.1 Flu Vaccine (Influenza Vaccine) Production Bases, Sales Regions and Major Competitors
    2.6.2.2 Flu Vaccine (Influenza Vaccine) Product Information
  2.6.3 Pfizer Flu Vaccine (Influenza Vaccine) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.6.3.1 Pfizer Flu Vaccine (Influenza Vaccine) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.6.3.2 Global Pfizer Flu Vaccine (Influenza Vaccine) Market Share in 2017
2.7 Johnson & Johnson
  2.7.1 Business Overview
    2.7.1.1 Johnson & Johnson Description
    2.7.1.2 Johnson & Johnson Headquarter, Main Business and Finance Overview
  2.7.2 Johnson & Johnson Flu Vaccine (Influenza Vaccine) Product Introduction
    2.7.2.1 Flu Vaccine (Influenza Vaccine) Production Bases, Sales Regions and Major Competitors
    2.7.2.2 Flu Vaccine (Influenza Vaccine) Product Information
  2.7.3 Johnson & Johnson Flu Vaccine (Influenza Vaccine) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.7.3.1 Johnson & Johnson Flu Vaccine (Influenza Vaccine) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.7.3.2 Global Johnson & Johnson Flu Vaccine (Influenza Vaccine) Market Share in 2017

3 GLOBAL FLU VACCINE (INFLUENZA VACCINE) MARKET COMPETITION, BY MANUFACTURER

3.1 Global Flu Vaccine (Influenza Vaccine) Sales and Market Share by Manufacturer (2016-2017)
3.2 Global Flu Vaccine (Influenza Vaccine) Revenue and Market Share by Manufacturer (2016-2017)
3.3 Global Flu Vaccine (Influenza Vaccine) Price by Manufacturer (2016-2017)
3.4 Market Concentration Rate
  3.4.1 Top 3 Flu Vaccine (Influenza Vaccine) Manufacturer Market Share in 2017
  3.4.2 Top 5 Flu Vaccine (Influenza Vaccine) Manufacturer Market Share in 2017
3.5 Market Competition Trend

4 GLOBAL FLU VACCINE (INFLUENZA VACCINE) MARKET ANALYSIS BY REGIONS

4.1 Global Flu Vaccine (Influenza Vaccine) Sales, Revenue and Market Share by Regions
  4.1.1 Global Flu Vaccine (Influenza Vaccine) Sales by Regions (2013-2018)
  4.1.2 Global Flu Vaccine (Influenza Vaccine) Revenue by Regions (2013-2018)
4.2 North America Flu Vaccine (Influenza Vaccine) Sales, Revenue and Growth Rate (2013-2018)
4.3 Europe Flu Vaccine (Influenza Vaccine) Sales, Revenue and Growth Rate (2013-2018)
4.4 Asia-Pacific Flu Vaccine (Influenza Vaccine) Sales, Revenue and Growth Rate (2013-2018)
4.5 South America Flu Vaccine (Influenza Vaccine) Sales, Revenue and Growth Rate (2013-2018)
4.6 Middle East and Africa Flu Vaccine (Influenza Vaccine) Sales, Revenue and Growth Rate (2013-2018)

5 NORTH AMERICA FLU VACCINE (INFLUENZA VACCINE) BY COUNTRIES, TYPE, APPLICATION AND MANUFACTURERS

5.1 North America Flu Vaccine (Influenza Vaccine) Sales, Revenue and Market Share by Countries
  5.1.1 North America Flu Vaccine (Influenza Vaccine) Sales by Countries (2013-2018)
  5.1.2 North America Flu Vaccine (Influenza Vaccine) Revenue by Countries (2013-2018)
  5.1.3 United States Flu Vaccine (Influenza Vaccine) Sales and Growth Rate (2013-2018)
  5.1.4 Canada Flu Vaccine (Influenza Vaccine) Sales and Growth Rate (2013-2018)
  5.1.5 Mexico Flu Vaccine (Influenza Vaccine) Sales and Growth Rate (2013-2018)
5.2 North America Flu Vaccine (Influenza Vaccine) Sales and Revenue (Value) by Manufacturers (2016-2017)
  5.2.1 North America Flu Vaccine (Influenza Vaccine) Sales by Manufacturers (2016-2017)
  5.2.2 North America Flu Vaccine (Influenza Vaccine) Revenue by Manufacturers (2016-2017)
5.3 North America Flu Vaccine (Influenza Vaccine) Sales, Revenue and Market Share by Type (2013-2018)
  5.3.1 North America Flu Vaccine (Influenza Vaccine) Sales and Sales Share by Type (2013-2018)
  5.3.2 North America Flu Vaccine (Influenza Vaccine) Revenue and Revenue Share by Type (2013-2018)
5.4 North America Flu Vaccine (Influenza Vaccine) Sales, Revenue and Market Share by Application (2013-2018)
  5.4.1 North America Flu Vaccine (Influenza Vaccine) Sales and Sales Share by Application (2013-2018)
  5.4.2 North America Flu Vaccine (Influenza Vaccine) Revenue and Revenue Share by Application (2013-2018)

6 EUROPE FLU VACCINE (INFLUENZA VACCINE) BY COUNTRIES, TYPE, APPLICATION AND MANUFACTURERS

6.1 Europe Flu Vaccine (Influenza Vaccine) Sales, Revenue and Market Share by Countries
  6.1.1 Europe Flu Vaccine (Influenza Vaccine) Sales by Countries (2013-2018)
  6.1.2 Europe Flu Vaccine (Influenza Vaccine) Revenue by Countries (2013-2018)
  6.1.3 Germany Flu Vaccine (Influenza Vaccine) Sales and Growth Rate (2013-2018)
  6.1.4 UK Flu Vaccine (Influenza Vaccine) Sales and Growth Rate (2013-2018)
  6.1.5 France Flu Vaccine (Influenza Vaccine) Sales and Growth Rate (2013-2018)
  6.1.6 Russia Flu Vaccine (Influenza Vaccine) Sales and Growth Rate (2013-2018)
  6.1.7 Italy Flu Vaccine (Influenza Vaccine) Sales and Growth Rate (2013-2018)
6.2 Europe Flu Vaccine (Influenza Vaccine) Sales and Revenue (Value) by Manufacturers (2016-2017)
  6.2.1 Europe Flu Vaccine (Influenza Vaccine) Sales by Manufacturers (2016-2017)
  6.2.2 Europe Flu Vaccine (Influenza Vaccine) Revenue by Manufacturers (2016-2017)
6.3 Europe Flu Vaccine (Influenza Vaccine) Sales, Revenue and Market Share by Type (2013-2018)
  6.3.1 Europe Flu Vaccine (Influenza Vaccine) Sales and Sales Share by Type (2013-2018)
  6.3.2 Europe Flu Vaccine (Influenza Vaccine) Revenue and Revenue Share by Type (2013-2018)
6.4 Europe Flu Vaccine (Influenza Vaccine) Sales, Revenue and Market Share by Application (2013-2018)
  6.4.1 Europe Flu Vaccine (Influenza Vaccine) Sales and Sales Share by Application (2013-2018)
  6.4.2 Europe Flu Vaccine (Influenza Vaccine) Revenue and Revenue Share by Application (2013-2018)

7 ASIA-PACIFIC FLU VACCINE (INFLUENZA VACCINE) BY COUNTRIES, TYPE, APPLICATION AND MANUFACTURERS

7.1 Asia-Pacific Flu Vaccine (Influenza Vaccine) Sales, Revenue and Market Share by Countries
  7.1.1 Asia-Pacific Flu Vaccine (Influenza Vaccine) Sales by Countries (2013-2018)
  7.1.2 Asia-Pacific Flu Vaccine (Influenza Vaccine) Revenue by Countries (2013-2018)
  7.1.3 China Flu Vaccine (Influenza Vaccine) Sales and Growth Rate (2013-2018)
  7.1.4 Japan Flu Vaccine (Influenza Vaccine) Sales and Growth Rate (2013-2018)
  7.1.5 Korea Flu Vaccine (Influenza Vaccine) Sales and Growth Rate (2013-2018)
  7.1.6 India Flu Vaccine (Influenza Vaccine) Sales and Growth Rate (2013-2018)
  7.1.7 Southeast Asia Flu Vaccine (Influenza Vaccine) Sales and Growth Rate (2013-2018)
7.2 Asia-Pacific Flu Vaccine (Influenza Vaccine) Sales and Revenue (Value) by Manufacturers (2016-2017)
  7.2.1 Asia-Pacific Flu Vaccine (Influenza Vaccine) Sales by Manufacturers (2016-2017)
  7.2.2 Asia-Pacific Flu Vaccine (Influenza Vaccine) Revenue by Manufacturers (2016-2017)
7.3 Asia-Pacific Flu Vaccine (Influenza Vaccine) Sales, Revenue and Market Share by Type (2013-2018)
  7.3.1 Asia-Pacific Flu Vaccine (Influenza Vaccine) Sales and Sales Share by Type (2013-2018)
  7.3.2 Asia-Pacific Flu Vaccine (Influenza Vaccine) Revenue and Revenue Share by Type (2013-2018)
7.4 Asia-Pacific Flu Vaccine (Influenza Vaccine) Sales, Revenue and Market Share by Application (2013-2018)
  7.4.1 Asia-Pacific Flu Vaccine (Influenza Vaccine) Sales and Sales Share by Application (2013-2018)
  7.4.2 Asia-Pacific Flu Vaccine (Influenza Vaccine) Revenue and Revenue Share by Application (2013-2018)

8 SOUTH AMERICA FLU VACCINE (INFLUENZA VACCINE) BY COUNTRIES, TYPE, APPLICATION AND MANUFACTURERS

8.1 South America Flu Vaccine (Influenza Vaccine) Sales, Revenue and Market Share by Countries
  8.1.1 South America Flu Vaccine (Influenza Vaccine) Sales by Countries (2013-2018)
  8.1.2 South America Flu Vaccine (Influenza Vaccine) Revenue by Countries (2013-2018)
  8.1.3 Brazil Flu Vaccine (Influenza Vaccine) Sales and Growth Rate (2013-2018)
  8.1.4 Argentina Flu Vaccine (Influenza Vaccine) Sales and Growth Rate (2013-2018)
  8.1.5 Colombia Flu Vaccine (Influenza Vaccine) Sales and Growth Rate (2013-2018)
8.2 South America Flu Vaccine (Influenza Vaccine) Sales and Revenue (Value) by Manufacturers (2016-2017)
  8.2.1 South America Flu Vaccine (Influenza Vaccine) Sales by Manufacturers (2016-2017)
  8.2.2 South America Flu Vaccine (Influenza Vaccine) Revenue by Manufacturers (2016-2017)
8.3 South America Flu Vaccine (Influenza Vaccine) Sales, Revenue and Market Share by Type (2013-2018)
  8.3.1 South America Flu Vaccine (Influenza Vaccine) Sales and Sales Share by Type (2013-2018)
  8.3.2 South America Flu Vaccine (Influenza Vaccine) Revenue and Revenue Share by Type (2013-2018)
8.4 South America Flu Vaccine (Influenza Vaccine) Sales, Revenue and Market Share by Application (2013-2018)
  8.4.1 South America Flu Vaccine (Influenza Vaccine) Sales and Sales Share by Application (2013-2018)
  8.4.2 South America Flu Vaccine (Influenza Vaccine) Revenue and Revenue Share by Application (2013-2018)

9 MIDDLE EAST AND AFRICA FLU VACCINE (INFLUENZA VACCINE) BY COUNTRIES, TYPE, APPLICATION AND MANUFACTURERS

9.1 Middle East and Africa Flu Vaccine (Influenza Vaccine) Sales, Revenue and Market Share by Countries
  9.1.1 Middle East and Africa Flu Vaccine (Influenza Vaccine) Sales by Countries (2013-2018)
  9.1.2 Middle East and Africa Flu Vaccine (Influenza Vaccine) Revenue by Countries (2013-2018)
  9.1.3 Saudi Arabia Flu Vaccine (Influenza Vaccine) Sales and Growth Rate (2013-2018)
  9.1.4 UAE Flu Vaccine (Influenza Vaccine) Sales and Growth Rate (2013-2018)
  9.1.5 Egypt Flu Vaccine (Influenza Vaccine) Sales and Growth Rate (2013-2018)
  9.1.6 Nigeria Flu Vaccine (Influenza Vaccine) Sales and Growth Rate (2013-2018)
  9.1.7 South Africa Flu Vaccine (Influenza Vaccine) Sales and Growth Rate (2013-2018)
9.2 Middle East and Africa Flu Vaccine (Influenza Vaccine) Sales and Revenue (Value) by Manufacturers (2016-2017)
  9.2.1 Middle East and Africa Flu Vaccine (Influenza Vaccine) Sales by Manufacturers (2016-2017)
  9.2.2 Middle East and Africa Flu Vaccine (Influenza Vaccine) Revenue by Manufacturers (2016-2017)
9.3 Middle East and Africa Flu Vaccine (Influenza Vaccine) Sales, Revenue and Market Share by Type (2013-2018)
  9.3.1 Middle East and Africa Flu Vaccine (Influenza Vaccine) Sales and Sales Share by Type (2013-2018)
  9.3.1 Middle East and Africa Flu Vaccine (Influenza Vaccine) Revenue and Revenue Share by Type (2013-2018)
9.4 Middle East and Africa Flu Vaccine (Influenza Vaccine) Sales, Revenue and Market Share by Application (2013-2018)
  9.4.1 Middle East and Africa Flu Vaccine (Influenza Vaccine) Sales and Sales Share by Application (2013-2018)
  9.4.2 Middle East and Africa Flu Vaccine (Influenza Vaccine) Revenue and Revenue Share by Application (2013-2018)

10 GLOBAL FLU VACCINE (INFLUENZA VACCINE) MARKET SEGMENT BY TYPE

10.1 Global Flu Vaccine (Influenza Vaccine) Sales, Revenue and Market Share by Type (2013-2018)
  10.1.1 Global Flu Vaccine (Influenza Vaccine) Sales and Market Share by Type (2013-2018)
  10.1.2 Global Flu Vaccine (Influenza Vaccine) Revenue and Market Share by Type (2013-2018)
10.2 Whole Virus Vaccines Sales Growth and Price
  10.2.1 Global Whole Virus Vaccines Sales Growth (2013-2018)
  10.2.2 Global Whole Virus Vaccines Price (2013-2018)
10.3 Split Virus Vaccines Sales Growth and Price
  10.3.1 Global Split Virus Vaccines Sales Growth (2013-2018)
  10.3.2 Global Split Virus Vaccines Price (2013-2018)
10.4 Subunit Vaccines Sales Growth and Price
  10.4.1 Global Subunit Vaccines Sales Growth (2013-2018)
  10.4.2 Global Subunit Vaccines Price (2013-2018)
10.5 Live Attenuated Virus Vaccines Sales Growth and Price
  10.5.1 Global Live Attenuated Virus Vaccines Sales Growth (2013-2018)
  10.5.2 Global Live Attenuated Virus Vaccines Price (2013-2018)

11 GLOBAL FLU VACCINE (INFLUENZA VACCINE) MARKET SEGMENT BY APPLICATION

11.1 Global Flu Vaccine (Influenza Vaccine) Sales Market Share by Application (2013-2018)
11.2 For Children (6 months to 3 years) Sales Growth (2013-2018)
11.3 For Adults and Children over 3 years Sales Growth (2013-2018)

12 FLU VACCINE (INFLUENZA VACCINE) MARKET FORECAST (2018-2023)

12.1 Global Flu Vaccine (Influenza Vaccine) Sales, Revenue and Growth Rate (2018-2023)
12.2 Flu Vaccine (Influenza Vaccine) Market Forecast by Regions (2018-2023)
  12.2.1 North America Flu Vaccine (Influenza Vaccine) Market Forecast (2018-2023)
  12.2.2 Europe Flu Vaccine (Influenza Vaccine) Market Forecast (2018-2023)
  12.2.3 Asia-Pacific Flu Vaccine (Influenza Vaccine) Market Forecast (2018-2023)
  12.2.4 South America Flu Vaccine (Influenza Vaccine) Market Forecast (2018-2023)
  12.2.5 Middle East and Africa Flu Vaccine (Influenza Vaccine) Market Forecast (2018-2023)
12.3 Flu Vaccine (Influenza Vaccine) Market Forecast by Type (2018-2023)
  12.3.1 Global Flu Vaccine (Influenza Vaccine) Sales Forecast by Type (2018-2023)
  12.3.2 Global Flu Vaccine (Influenza Vaccine) Market Share Forecast by Type (2018-2023)
12.4 Flu Vaccine (Influenza Vaccine) Market Forecast by Application (2018-2023)
  12.4.1 Global Flu Vaccine (Influenza Vaccine) Sales Forecast by Application (2018-2023)
  12.4.2 Global Flu Vaccine (Influenza Vaccine) Market Share Forecast by Application (2018-2023)

13 SALES CHANNEL, DISTRIBUTORS, TRADERS AND DEALERS

13.1 Sales Channel
  13.1.1 Direct Marketing
  13.1.2 Indirect Marketing
  13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers

14 RESEARCH FINDINGS AND CONCLUSION

15 APPENDIX

15.1 Methodology
15.2 Data Source
LIST OF TABLES AND FIGURES

Figure Flu Vaccine (Influenza Vaccine) Picture
Table Product Specifications of Flu Vaccine (Influenza Vaccine)
Figure Global Flu Vaccine (Influenza Vaccine) CAGR (%), Y-o-Y Growth (&) and Market Size, 2013-2023 (USD Million)
Figure Global Flu Vaccine (Influenza Vaccine) CAGR (%), Y-o-Y Growth (&) and Market Size, 2013-2023 (Sales)
Figure Global Sales Market Share of Flu Vaccine (Influenza Vaccine) by Types in 2017
Figure Whole Virus Vaccines Picture
Table Major Manufacturers of Whole Virus Vaccines
Figure Split Virus Vaccines Picture
Table Major Manufacturers of Split Virus Vaccines
Figure Subunit Vaccines Picture
Table Major Manufacturers of Subunit Vaccines
Figure Live Attenuated Virus Vaccines Picture
Table Major Manufacturers of Live Attenuated Virus Vaccines
Figure Flu Vaccine (Influenza Vaccine) Sales Market Share by Applications in 2017
Figure For Children (6 months to 3 years) Picture
Figure For Adults and Children over 3 years Picture
Figure United States Flu Vaccine (Influenza Vaccine) Revenue (Value) and Growth Rate (2013-2023)
Figure Canada Flu Vaccine (Influenza Vaccine) Revenue (Value) and Growth Rate (2013-2023)
Figure Mexico Flu Vaccine (Influenza Vaccine) Revenue (Value) and Growth Rate (2013-2023)
Figure Germany Flu Vaccine (Influenza Vaccine) Revenue (Value) and Growth Rate (2013-2023)
Figure France Flu Vaccine (Influenza Vaccine) Revenue (Value) and Growth Rate (2013-2023)
Figure UK Flu Vaccine (Influenza Vaccine) Revenue (Value) and Growth Rate (2013-2023)
Figure Russia Flu Vaccine (Influenza Vaccine) Revenue (Value) and Growth Rate (2013-2023)
Figure Italy Flu Vaccine (Influenza Vaccine) Revenue (Value) and Growth Rate (2013-2023)
Figure China Flu Vaccine (Influenza Vaccine) Revenue (Value) and Growth Rate (2013-2023)
Figure Japan Flu Vaccine (Influenza Vaccine) Revenue (Value) and Growth Rate (2013-2023)
Figure Korea Flu Vaccine (Influenza Vaccine) Revenue (Value) and Growth Rate (2013-2023)
Figure India Flu Vaccine (Influenza Vaccine) Revenue (Value) and Growth Rate (2013-2023)
Figure Southeast Asia Flu Vaccine (Influenza Vaccine) Revenue (Value) and Growth Rate (2013-2023)
Figure Brazil Flu Vaccine (Influenza Vaccine) Revenue (Value) and Growth Rate (2013-2023)
Figure Egypt Flu Vaccine (Influenza Vaccine) Revenue (Value) and Growth Rate (2013-2023)
Figure Saudi Arabia Flu Vaccine (Influenza Vaccine) Revenue (Value) and Growth Rate (2013-2023)
Figure South Africa Flu Vaccine (Influenza Vaccine) Revenue (Value) and Growth Rate (2013-2023)
Figure Nigeria Flu Vaccine (Influenza Vaccine) Revenue (Value) and Growth Rate (2013-2023)
Table CSL Headquarter, Established, Main Business and Finance Overview (2017)
Table CSL Flu Vaccine (Influenza Vaccine) Production Bases, Sales Regions and Major Competitors
Table CSL Flu Vaccine (Influenza Vaccine) Product
Table CSL Flu Vaccine (Influenza Vaccine) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global CSL Flu Vaccine (Influenza Vaccine) Sales Market Share in 2017
Figure Global CSL Flu Vaccine (Influenza Vaccine) Revenue Market Share in 2017
Table GSK Headquarter, Established, Main Business and Finance Overview (2017)
Table GSK Flu Vaccine (Influenza Vaccine) Production Bases, Sales Regions and Major Competitors
Table GSK Flu Vaccine (Influenza Vaccine) Product
Table GSK Flu Vaccine (Influenza Vaccine) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global GSK Flu Vaccine (Influenza Vaccine) Sales Market Share in 2017
Figure Global GSK Flu Vaccine (Influenza Vaccine) Revenue Market Share in 2017
Table Sanofi Pasteur Headquarter, Established, Main Business and Finance Overview (2017)
Table Sanofi Pasteur Flu Vaccine (Influenza Vaccine) Production Bases, Sales Regions and Major Competitors
Table Sanofi Pasteur Flu Vaccine (Influenza Vaccine) Product
Table Sanofi Pasteur Flu Vaccine (Influenza Vaccine) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Sanofi Pasteur Flu Vaccine (Influenza Vaccine) Sales Market Share in 2017
Figure Global Sanofi Pasteur Flu Vaccine (Influenza Vaccine) Revenue Market Share in 2017
Table Mylan Headquarter, Established, Main Business and Finance Overview (2017)
Table Mylan Flu Vaccine (Influenza Vaccine) Production Bases, Sales Regions and Major Competitors
Table Mylan Flu Vaccine (Influenza Vaccine) Product
Table Mylan Flu Vaccine (Influenza Vaccine) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Mylan Flu Vaccine (Influenza Vaccine) Sales Market Share in 2017
Figure Global Mylan Flu Vaccine (Influenza Vaccine) Revenue Market Share in 2017
Table AstraZeneca Headquarter, Established, Main Business and Finance Overview (2017)
Table AstraZeneca Flu Vaccine (Influenza Vaccine) Production Bases, Sales Regions and Major Competitors
Table AstraZeneca Flu Vaccine (Influenza Vaccine) Product
Table AstraZeneca Flu Vaccine (Influenza Vaccine) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global AstraZeneca Flu Vaccine (Influenza Vaccine) Sales Market Share in 2017
Figure Global AstraZeneca Flu Vaccine (Influenza Vaccine) Revenue Market Share in 2017
Table Pfizer Headquarter, Established, Main Business and Finance Overview (2017)
Table Pfizer Flu Vaccine (Influenza Vaccine) Production Bases, Sales Regions and Major Competitors
Table Pfizer Flu Vaccine (Influenza Vaccine) Product
Table Pfizer Flu Vaccine (Influenza Vaccine) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Pfizer Flu Vaccine (Influenza Vaccine) Sales Market Share in 2017
Figure Global Pfizer Flu Vaccine (Influenza Vaccine) Revenue Market Share in 2017
Table Johnson & Johnson Headquarter, Established, Main Business and Finance Overview (2017)
Table Johnson & Johnson Flu Vaccine (Influenza Vaccine) Production Bases, Sales Regions and Major Competitors
Table Johnson & Johnson Flu Vaccine (Influenza Vaccine) Product
Table Johnson & Johnson Flu Vaccine (Influenza Vaccine) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Johnson & Johnson Flu Vaccine (Influenza Vaccine) Sales Market Share in 2017
Figure Global Johnson & Johnson Flu Vaccine (Influenza Vaccine) Revenue Market Share in 2017
Table Global Flu Vaccine (Influenza Vaccine) Sales by Manufacturer (2016-2017)
Figure Global Flu Vaccine (Influenza Vaccine) Sales Market Share by Manufacturer in 2016
Figure Global Flu Vaccine (Influenza Vaccine) Sales Market Share by Manufacturer in 2017
Table Global Flu Vaccine (Influenza Vaccine) Revenue by Manufacturer (2016-2017)
Figure Global Flu Vaccine (Influenza Vaccine) Revenue Market Share by Manufacturer in 2016
Figure Global Flu Vaccine (Influenza Vaccine) Revenue Market Share by Manufacturer in 2017
Table Global Flu Vaccine (Influenza Vaccine) Price by Manufacturer (2016-2017)
Figure Top 3 Flu Vaccine (Influenza Vaccine) Manufacturer (Revenue) Market Share in 2017
Figure Top 6 Flu Vaccine (Influenza Vaccine) Manufacturer (Revenue) Market Share in 2017
Figure Global Flu Vaccine (Influenza Vaccine) Sales and Growth Rate (2013-2018)
Figure Global Flu Vaccine (Influenza Vaccine) Revenue and Growth Rate (2013-2018)
Table Global Flu Vaccine (Influenza Vaccine) Sales by Regions (2013-2018)
Table Global Flu Vaccine (Influenza Vaccine) Sales Market Share by Regions (2013-2018)
Table Global Flu Vaccine (Influenza Vaccine) Revenue by Regions (2013-2018)
Figure Global Flu Vaccine (Influenza Vaccine) Revenue Market Share by Regions in 2013
Figure Global Flu Vaccine (Influenza Vaccine) Revenue Market Share by Regions in 2017
Figure North America Flu Vaccine (Influenza Vaccine) Sales and Growth Rate (2013-2018)
Figure North America Flu Vaccine (Influenza Vaccine) Revenue and Growth Rate (2013-2018)
Figure Europe Flu Vaccine (Influenza Vaccine) Sales and Growth Rate (2013-2018)
Figure Europe Flu Vaccine (Influenza Vaccine) Revenue and Growth Rate (2013-2018)
Figure Asia-Pacific Flu Vaccine (Influenza Vaccine) Sales and Growth Rate (2013-2018)
Figure Asia-Pacific Flu Vaccine (Influenza Vaccine) Revenue and Growth Rate (2013-2018)
Figure South America Flu Vaccine (Influenza Vaccine) Sales and Growth Rate (2013-2018)
Figure South America Flu Vaccine (Influenza Vaccine) Revenue and Growth Rate (2013-2018)
Figure Middle East and Africa Flu Vaccine (Influenza Vaccine) Sales and Growth Rate (2013-2018)
Figure Middle East and Africa Flu Vaccine (Influenza Vaccine) Revenue and Growth Rate (2013-2018)
Figure North America Flu Vaccine (Influenza Vaccine) Revenue and Growth Rate (2013-2018)
Table North America Flu Vaccine (Influenza Vaccine) Sales by Countries (2013-2018)
Table North America Flu Vaccine (Influenza Vaccine) Sales Market Share by Countries (2013-2018)
Figure North America Flu Vaccine (Influenza Vaccine) Sales Market Share by Countries in 2013
Figure North America Flu Vaccine (Influenza Vaccine) Sales Market Share by Countries in 2017
Table North America Flu Vaccine (Influenza Vaccine) Revenue by Countries (2013-2018)
Table North America Flu Vaccine (Influenza Vaccine) Revenue Market Share by Countries (2013-2018)
Figure North America Flu Vaccine (Influenza Vaccine) Revenue Market Share by Countries in 2013
Figure North America Flu Vaccine (Influenza Vaccine) Revenue Market Share by Countries in 2017
Figure United States Flu Vaccine (Influenza Vaccine) Sales and Growth Rate (2013-2018)
Figure Canada Flu Vaccine (Influenza Vaccine) Sales and Growth Rate (2013-2018)
Figure Mexico Flu Vaccine (Influenza Vaccine) Sales and Growth Rate (2013-2018)
Table North America Flu Vaccine (Influenza Vaccine) Sales by Manufacturer (2016-2017)
Figure North America Flu Vaccine (Influenza Vaccine) Sales Market Share by Manufacturer in 2016
Figure North America Flu Vaccine (Influenza Vaccine) Sales Market Share by Manufacturer in 2017
Table North America Flu Vaccine (Influenza Vaccine) Revenue by Manufacturer (2016-2017)
Figure North America Flu Vaccine (Influenza Vaccine) Revenue Market Share by Manufacturer in 2016
Figure North America Flu Vaccine (Influenza Vaccine) Revenue Market Share by Manufacturer in 2017
Table North America Flu Vaccine (Influenza Vaccine) Sales by Type (2013-2018)
Table North America Flu Vaccine (Influenza Vaccine) Sales Share by Type (2013-2018)
Table North America Flu Vaccine (Influenza Vaccine) Revenue by Type (2013-2018)
Table North America Flu Vaccine (Influenza Vaccine) Revenue Share by Type (2013-2018)
Table North America Flu Vaccine (Influenza Vaccine) Sales by Application (2013-2018)
Table North America Flu Vaccine (Influenza Vaccine) Sales Share by Application (2013-2018)
Table North America Flu Vaccine (Influenza Vaccine) Revenue by Application (2013-2018)
Table North America Flu Vaccine (Influenza Vaccine) Revenue Share by Application (2013-2018)
Figure Europe Flu Vaccine (Influenza Vaccine) Revenue and Growth Rate (2013-2018)
Table Europe Flu Vaccine (Influenza Vaccine) Sales by Countries (2013-2018)
Table Europe Flu Vaccine (Influenza Vaccine) Sales Market Share by Countries (2013-2018)
Table Europe Flu Vaccine (Influenza Vaccine) Revenue by Countries (2013-2018)
Figure Europe Flu Vaccine (Influenza Vaccine) Revenue Market Share by Countries in 2016
Figure Europe Flu Vaccine (Influenza Vaccine) Revenue Market Share by Countries in 2017
Figure Germany Flu Vaccine (Influenza Vaccine) Sales and Growth Rate (2013-2018)
Figure UK Flu Vaccine (Influenza Vaccine) Sales and Growth Rate (2013-2018)
Figure France Flu Vaccine (Influenza Vaccine) Sales and Growth Rate (2013-2018)
Figure Russia Flu Vaccine (Influenza Vaccine) Sales and Growth Rate (2013-2018)
Figure Italy Flu Vaccine (Influenza Vaccine) Sales and Growth Rate (2013-2018)
Table Europe Flu Vaccine (Influenza Vaccine) Sales by Manufacturer (2016-2017)
Figure Europe Flu Vaccine (Influenza Vaccine) Sales Market Share by Manufacturer in 2016
Figure Europe Flu Vaccine (Influenza Vaccine) Sales Market Share by Manufacturer in 2017
Table Europe Flu Vaccine (Influenza Vaccine) Revenue by Manufacturer (2016-2017)
Figure Europe Flu Vaccine (Influenza Vaccine) Revenue Market Share by Manufacturer in 2016
Figure Europe Flu Vaccine (Influenza Vaccine) Revenue Market Share by Manufacturer in 2017
Table Europe Flu Vaccine (Influenza Vaccine) Sales by Type (2013-2018)
Table Europe Flu Vaccine (Influenza Vaccine) Sales Share by Type (2013-2018)
Table Europe Flu Vaccine (Influenza Vaccine) Revenue by Type (2013-2018)
Table Europe Flu Vaccine (Influenza Vaccine) Revenue Share by Type (2013-2018)
Table Europe Flu Vaccine (Influenza Vaccine) Sales by Application (2013-2018)
Table Europe Flu Vaccine (Influenza Vaccine) Sales Share by Application (2013-2018)
Table Europe Flu Vaccine (Influenza Vaccine) Revenue by Application (2013-2018)
Table Europe Flu Vaccine (Influenza Vaccine) Revenue Share by Application (2013-2018)
Figure Asia-Pacific Flu Vaccine (Influenza Vaccine) Revenue and Growth Rate (2013-2018)
Table Asia-Pacific Flu Vaccine (Influenza Vaccine) Sales by Countries (2013-2018)
Table Asia-Pacific Flu Vaccine (Influenza Vaccine) Sales Market Share by Countries (2013-2018)
Figure Asia-Pacific Flu Vaccine (Influenza Vaccine) Sales Market Share by Countries 2017
Table Asia-Pacific Flu Vaccine (Influenza Vaccine) Revenue by Countries (2013-2018)
Figure Asia-Pacific Flu Vaccine (Influenza Vaccine) Revenue Market Share by Countries 2017
Figure China Flu Vaccine (Influenza Vaccine) Sales and Growth Rate (2013-2018)
Figure Japan Flu Vaccine (Influenza Vaccine) Sales and Growth Rate (2013-2018)
Figure Korea Flu Vaccine (Influenza Vaccine) Sales and Growth Rate (2013-2018)
Figure India Flu Vaccine (Influenza Vaccine) Sales and Growth Rate (2013-2018)
Figure Southeast Asia Flu Vaccine (Influenza Vaccine) Sales and Growth Rate (2013-2018)
Table Asia-Pacific Flu Vaccine (Influenza Vaccine) Sales by Manufacturer (2016-2017)
Figure Asia-Pacific Flu Vaccine (Influenza Vaccine) Sales Market Share by Manufacturer in 2016
Figure Asia-Pacific Flu Vaccine (Influenza Vaccine) Sales Market Share by Manufacturer in 2017
Table Asia-Pacific Flu Vaccine (Influenza Vaccine) Revenue by Manufacturer (2016-2017)
Figure Asia-Pacific Flu Vaccine (Influenza Vaccine) Revenue Market Share by Manufacturer in 2016
Figure Asia-Pacific Flu Vaccine (Influenza Vaccine) Revenue Market Share by Manufacturer in 2017
Table Asia-Pacific Flu Vaccine (Influenza Vaccine) Sales by Type (2013-2018)
Table Asia-Pacific Flu Vaccine (Influenza Vaccine) Sales Share by Type (2013-2018)
Table Asia-Pacific Flu Vaccine (Influenza Vaccine) Revenue by Type (2013-2018)
Table Asia-Pacific Flu Vaccine (Influenza Vaccine) Revenue Share by Type (2013-2018)
Table Asia-Pacific Flu Vaccine (Influenza Vaccine) Sales by Application (2013-2018)
Table Asia-Pacific Flu Vaccine (Influenza Vaccine) Sales Share by Application (2013-2018)
Table Asia-Pacific Flu Vaccine (Influenza Vaccine) Revenue by Application (2013-2018)
Table Asia-Pacific Flu Vaccine (Influenza Vaccine) Revenue Share by Application (2013-2018)
Figure South America Flu Vaccine (Influenza Vaccine) Revenue and Growth Rate (2013-2018)
Table South America Flu Vaccine (Influenza Vaccine) Sales by Countries (2013-2018)
Table South America Flu Vaccine (Influenza Vaccine) Sales Market Share by Countries (2013-2018)
Figure South America Flu Vaccine (Influenza Vaccine) Sales Market Share by Countries in 2017
Table South America Flu Vaccine (Influenza Vaccine) Revenue by Countries (2013-2018)
Table South America Flu Vaccine (Influenza Vaccine) Revenue Market Share by Countries (2013-2018)
Figure South America Flu Vaccine (Influenza Vaccine) Revenue Market Share by Countries in 2017
Figure Brazil Flu Vaccine (Influenza Vaccine) Sales and Growth Rate (2013-2018)
Figure Argentina Flu Vaccine (Influenza Vaccine) Sales and Growth Rate (2013-2018)
Figure Colombia Flu Vaccine (Influenza Vaccine) Sales and Growth Rate (2013-2018)
Table South America Flu Vaccine (Influenza Vaccine) Sales by Manufacturer (2016-2017)
Figure South America Flu Vaccine (Influenza Vaccine) Sales Market Share by Manufacturer in 2016
Figure South America Flu Vaccine (Influenza Vaccine) Sales Market Share by Manufacturer in 2017
Table South America Flu Vaccine (Influenza Vaccine) Revenue by Manufacturer (2016-2017)
Figure South America Flu Vaccine (Influenza Vaccine) Revenue Market Share by Manufacturer in 2016
Figure South America Flu Vaccine (Influenza Vaccine) Revenue Market Share by Manufacturer in 2017
Table South America Flu Vaccine (Influenza Vaccine) Sales by Type (2013-2018)
Table South America Flu Vaccine (Influenza Vaccine) Sales Share by Type (2013-2018)
Table South America Flu Vaccine (Influenza Vaccine) Revenue by Type (2013-2018)
Table South America Flu Vaccine (Influenza Vaccine) Revenue Share by Type (2013-2018)
Table South America Flu Vaccine (Influenza Vaccine) Sales by Application (2013-2018)
Table South America Flu Vaccine (Influenza Vaccine) Sales Share by Application (2013-2018)
Table South America Flu Vaccine (Influenza Vaccine) Revenue by Application (2013-2018)
Table South America Flu Vaccine (Influenza Vaccine) Revenue Share by Application (2013-2018)
Figure Middle East and Africa Flu Vaccine (Influenza Vaccine) Revenue and Growth Rate (2013-2018)
Table Middle East and Africa Flu Vaccine (Influenza Vaccine) Sales by Countries (2013-2018)
Table Middle East and Africa Flu Vaccine (Influenza Vaccine) Sales Market Share by Countries (2013-2018)
Figure Middle East and Africa Flu Vaccine (Influenza Vaccine) Sales Market Share by Countries in 2017
Table Middle East and Africa Flu Vaccine (Influenza Vaccine) Revenue by Countries (2013-2018)
Table Middle East and Africa Flu Vaccine (Influenza Vaccine) Revenue Market Share by Countries (2013-2018)
Figure Middle East and Africa Flu Vaccine (Influenza Vaccine) Revenue Market Share by Countries in 2013
Figure Middle East and Africa Flu Vaccine (Influenza Vaccine) Revenue Market Share by Countries in 2017
Figure Saudi Arabia Flu Vaccine (Influenza Vaccine) Sales and Growth Rate (2013-2018)
Figure UAE Flu Vaccine (Influenza Vaccine) Sales and Growth Rate (2013-2018)
Figure Egypt Flu Vaccine (Influenza Vaccine) Sales and Growth Rate (2013-2018)
Figure Nigeria Flu Vaccine (Influenza Vaccine) Sales and Growth Rate (2013-2018)
Figure South Africa Flu Vaccine (Influenza Vaccine) Sales and Growth Rate (2013-2018)
Table Middle East and Africa Flu Vaccine (Influenza Vaccine) Sales by Manufacturer (2016-2017)
Figure Middle East and Africa Flu Vaccine (Influenza Vaccine) Sales Market Share by Manufacturer in 2016
Figure Middle East and Africa Flu Vaccine (Influenza Vaccine) Sales Market Share by Manufacturer in 2017
Table Middle East and Africa Flu Vaccine (Influenza Vaccine) Revenue by Manufacturer (2016-2017)
Figure Middle East and Africa Flu Vaccine (Influenza Vaccine) Revenue Market Share by Manufacturer in 2016
Figure Middle East and Africa Flu Vaccine (Influenza Vaccine) Revenue Market Share by Manufacturer in 2017
Table Middle East and Africa Flu Vaccine (Influenza Vaccine) Sales by Type (2013-2018)
Table Middle East and Africa Flu Vaccine (Influenza Vaccine) Sales Share by Type (2013-2018)
Table Middle East and Africa Flu Vaccine (Influenza Vaccine) Revenue by Type (2013-2018)
Table Middle East and Africa Flu Vaccine (Influenza Vaccine) Revenue Share by Type (2013-2018)
Table Middle East and Africa Flu Vaccine (Influenza Vaccine) Sales by Application (2013-2018)
Table Middle East and Africa Flu Vaccine (Influenza Vaccine) Sales Share by Application (2013-2018)
Table Middle East and Africa Flu Vaccine (Influenza Vaccine) Revenue by Application (2013-2018)
Table Middle East and Africa Flu Vaccine (Influenza Vaccine) Revenue Share by Application (2013-2018)
Table Global Flu Vaccine (Influenza Vaccine) Sales by Type (2013-2018)
Table Global Flu Vaccine (Influenza Vaccine) Sales Share by Type (2013-2018)
Table Global Flu Vaccine (Influenza Vaccine) Revenue by Type (2013-2018)
Table Global Flu Vaccine (Influenza Vaccine) Revenue Share by Type (2013-2018)
Figure Global Whole Virus Vaccines Sales Growth (2013-2018)
Figure Global Whole Virus Vaccines Price (2013-2018)
Figure Global Split Virus Vaccines Sales Growth (2013-2018)
Figure Global Split Virus Vaccines Price (2013-2018)
Figure Global Subunit Vaccines Sales Growth (2013-2018)
Figure Global Subunit Vaccines Price (2013-2018)
Figure Global Live Attenuated Virus Vaccines Sales Growth (2013-2018)
Figure Global Live Attenuated Virus Vaccines Price (2013-2018)
Table Global Flu Vaccine (Influenza Vaccine) Sales by Application (2013-2018)
Table Global Flu Vaccine (Influenza Vaccine) Sales Share by Application (2013-2018)
Figure Global For Children (6 months to 3 years) Sales Growth (2013-2018)
Figure Global For Adults and Children over 3 years Sales Growth (2013-2018)
Figure Global Flu Vaccine (Influenza Vaccine) Sales, Revenue and Growth Rate (2018-2023)
Table Global Flu Vaccine (Influenza Vaccine) Sales Forecast by Regions (2018-2023)
Table Global Flu Vaccine (Influenza Vaccine) Market Share Forecast by Regions (2018-2023)
Figure North America Sales Flu Vaccine (Influenza Vaccine) Market Forecast (2018-2023)
Figure Europe Sales Flu Vaccine (Influenza Vaccine) Market Forecast (2018-2023)
Figure Asia-Pacific Sales Flu Vaccine (Influenza Vaccine) Market Forecast (2018-2023)
Figure South America Sales Flu Vaccine (Influenza Vaccine) Market Forecast (2018-2023)
Figure Middle East and Africa Sales Flu Vaccine (Influenza Vaccine) Market Forecast (2018-2023)
Table Global Flu Vaccine (Influenza Vaccine) Sales Forecast by Type (2018-2023)
Table Global Flu Vaccine (Influenza Vaccine) Market Share Forecast by Type (2018-2023)
Table Global Flu Vaccine (Influenza Vaccine) Sales Forecast by Application (2018-2023)
Table Global Flu Vaccine (Influenza Vaccine) Market Share Forecast by Application (2018-2023)
Table Distributors/Traders/ Dealers List


More Publications